UNSPSC 51281658: Neomycin e

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H45N5O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 61JJC8N5ZK, chemically known as diamino-2,6-dideoxy-.beta.-l-idopyranosyl-(1->3)-o-.beta.-d-ribofuranosyl-(1->5)-o-(2-amino-2-deoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxystreptamine, but more generally known as neomycin e, which bears US NIH Compound Identifier 24176.

European Medicines Agency schedules neomycin e or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03406MIG. Most nations, for tariff purposes, schedule neomycin e under HS 29419000. SMILES: C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N.

UNSPSC 51281658 Neomycin e is a Commodity code, but the recent state and local opportunities solicited under this code do not align with neomycin—a topical antibiotic ointment. Instead, procurement activity tagged to this code centers on naloxone (an opioid-reversal medication), generic multi-source pharmaceuticals, OTC products, and medical and first aid supplies for emergency response and pharmacy benefit programs. The issuing bodies span county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota MMCAP). The scope of actual work being solicited includes annual procurement of naloxone and drug deactivation systems for community health initiatives; establishment of statewide generic pharmaceutical and OTC supply contracts through authorized wholesalers; and medical consumables (respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, bandaging materials, oxygen delivery systems) for emergency response operations. Quantities range from hundreds of units annually for specialty items to tens of thousands for high-volume supplies, with contract terms typically one to two years and renewal options common.

Geographic activity appears concentrated in the Southeast and Upper Midwest, with recent solicitations from Florida, Texas, and Minnesota (including cross-state cooperative purchasing). The Seminole County IFB 60459723LAS, posted June 30, 2026, with a due date of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually via sealed electronic bid to the Seminole County Community Health Building in Sanford, Florida. The City of Tampa's IFB 26P00145, posted March 25, 2026, with responses due March 13, 2026, solicited 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division under a $700,000 estimated contract amount, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota MMCAP RFP S1070000015802, posted January 20, 2026, with responses due March 26, 2026, sought multiple manufacturers for generic pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with wholesaler distribution through AmerisourceBergen, Cardinal Health, and Morris & Dickson. The Texas HHS RFI HHS0017013, posted April 3, 2026, represents exploratory procurement focused on direct-to-manufacturer prescription fulfillment capability outside traditional pharmacy benefit manager channels, signaling state interest in alternative pharmaceutical supply models.